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Abstract
Several reports suggest obesity and bipolar disorder (BD) share some physiological and
behavioural similarities. For instance, obese individuals are more impulsive and have
heightened reward responsiveness, phenotypes associated with BD, while bipolar patients
become obese at a higher rate and earlier age than people without BD; however, the molec-
ular mechanisms of such an association remain obscure. Here we demonstrate, using
whole transcriptome analysis, that Drosophila Ets96B, homologue of obesity-linked gene
ETV5, regulates cellular systems associated with obesity and BD. Consistent with a role in
obesity and BD, loss of nervous system Ets96B during development increases triacylglycer-
ide concentration, while inducing a heightened startle-response, as well as increasing
hyperactivity and reducing sleep. Of notable interest, mouse Etv5 and Drosophila Ets96B
are expressed in dopaminergic-rich regions, and loss of Ets96B specifically in dopaminergic
neurons recapitulates the metabolic and behavioural phenotypes. Moreover, our data indi-
cate Ets96B inhibits dopaminergic-specific neuroprotective systems. Additionally, we reveal
that multiple SNPs in human ETV5 link to body mass index (BMI) and BD, providing further
evidence for ETV5 as an important and novel molecular intermediate between obesity and
BD. We identify a novel molecular link between obesity and bipolar disorder. The Drosophila
ETV5 homologue Ets96B regulates the expression of cellular systems with links to obesity
and behaviour, including the expression of a conserved endoplasmic reticulum molecular
chaperone complex known to be neuroprotective. Finally, a connection between the obe-
sity-linked gene ETV5 and bipolar disorder emphasizes a functional relationship between
obesity and BD at the molecular level.
Author Summary
The World Health Organization suggests obesity is a major cause of poor health and is
becoming the leading public health concern. Likewise, mood-based disorders, such as
bipolar disorder, are one of the top ten causes of disability worldwide. There is evidence
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that obesity and bipolar disorder may be linked and that obesity may exacerbate bipolar
disorder symptoms. For the first time, our work evidences a molecular-link between obe-
sity and bipolar disorder. In humans the obesity-linked gene ETV5 was also associated
with bipolar disorder. Using the model organism Drosophila melanogaster (the fruit fly)
we show that the ETV5 homologue Ets96B regulates a series of genes known to be neuro-
protective and inhibiting the expression of Ets96 in dopaminergic neurons induces pheno-
types linked to obesity and bipolar disorder, including increased lipid storage, increased
anxiety and reduced sleep. Our work will help to further the understanding of how these
to disorders may interact.
Introduction
Clinical studies indicate there may be a link between obesity and bipolar disorder (BD). Obese
individuals have greater impulsivity and reward responsiveness—phenotypes associated with
BD [1, 2], while bipolar patients become obese and have cardiovascular disorders at a higher
rate and earlier age than people without BD [3]. Although some studies link obesity and its
sequelae to BD medication, a significant number of medication-naïve BD patients also display
metabolic syndrome phenotypes [4, 5]. Moreover, BD patients have high rates of carbohydrate
consumption and low rates of physical exercise [6, 7]. Hence, there seem to be several physio-
logical and behavioural links between obesity and BD; however, the molecular mechanisms
connecting these two diseases are not fully understood.
Ets variant 5 (ETV5, also known as ERM), an E-twenty-six (ETS) transcription factor
belonging to the polyoma enhancer activator 3 (PEA3)-subfamily (ETV1, ETV4 and ETV5),
was initially linked to BMI in a GWAS study [8]. Experimental evidence in mice also links Etv5
to the regulation of metabolic homeostasis; Etv5 transcriptional expression is affected by inges-
tion of a high-fat/high-sugar diet, as well as food restriction [9, 10]. Moreover, Etv5-/- mice
exhibit decreased body weight compared to controls [9, 10]. In mouse brain, Etv5 is expressed
in the arcuate nucleus (ARC), ventro-medial hypothalamus (VMH), substantia nigra (SN), and
the ventral tegmental area (VTA) [9]. Expression in the ARC and VTA implies involvement in
reward-driven or energy-driven food intake [11]. Interestingly, these same regions regulate
impulsivity [12]. Also, the SN is a key regulator of locomotion and disruptions in this region
lead to hyperactivity [13].
The endoplasmic reticulum (ER) is involved in the biosynthesis, folding, modification and
trafficking of proteins. Apart from this role there is emerging evidence that the ER is centrally
involved in sensing metabolic changes within a cell and transmitting this information to the
nucleus [14]. Preclinical and clinical studies in the last decade indicate that ER stress, including
the unfolded protein response (UPR), has a significant impact on the pathogenesis of obesity
[15, 16]. Additionally, recent studies suggest an involvement of UPR in the pathophysiology of
BD [17, 18].
We turned to the genetically tractable model organism Drosophila melanogaster to under-
stand more about the molecular mechanism of how the PEA3-family member ETV5may affect
body weight and BD. In Drosophila the PEA3-family is represented by the homologue Ets96B.
Almost nothing is known about Ets96B, but it is highly expressed in the central nervous system
[19]. We knocked down Ets96B expression in the Drosophila nervous system and performed
SOLiD sequencing of the entire transcriptome, discovering associations to gene networks
whose human homologues are connected to body mass index (BMI) and bipolar disorder. Fur-
thermore, loss of neuronal Ets96B induced lipid storage defects, hyperactivity, and a
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heightened startle-response phenotype. Interestingly, our data indicate that Ets96B works to
suppress an ER molecular chaperone system shown to be neuroprotective in dopaminergic
neurons [20, 21]. Finally, we reveal a human association of ETV5 with bipolar disorder.
Results
Ets96B is a member of the PEA3 subfamily
To begin our studies we confirmed that Drosophila Ets96B was homologous to human ETV5.
Using the Maximum-likelihood method, the phylogenetic relationship between the Drosophila
protein Ets96B and vertebrate PEA3-family proteins was determined (Fig 1A). All major verte-
brate and invertebrate model organisms, where a PEA3-like protein existed that had an E-
value of at least 1.0e-45 when compared to human ETV5, were included. The mammalian
ETV2 subgroup was used as an outgroup. From the tree produced it was evident that inverte-
brates contained only one PEA3-family member, while the vertebrate family expanded to
include three members: ETV1, ETV4, and ETV5. We also searched for PEA3-family homo-
logues in the important model organisms S. cerevisae and D. discoideum by mining the NCBI’s
protein database nr using protein PSI-BLAST with Drosophila Ets96B, as well as vertebrate
ETV1, ETV4, and ETV5 protein sequences as queries, but no homologous proteins were dis-
covered. From this data we conclude that Drosophila melanogaster Ets96B is basally related to
the vertebrate PEA3-subfamily of ETS transcription factors.
A multiple sequence alignment was performed comparingDrosophila Ets96B with human
PEA3-family proteins (Fig 1B). This alignment demonstrated that the ETS domain at the C-termi-
nus, found in all ETS-family proteins, was well conserved (Fig 1B, dark blue underlining). Although
some conservation was observed in the N-terminus, the PEA3 domain, present in all mammalian
PEA3 family members, was not conserved. In regards to regulatory conservation, mammalian
ETV5 is sumoylated on multiple sites, necessary for the inhibition of ETV5 activity [22]. These
sumoylation sites were conserved in all human PEA3-family members (Fig 1B, black underlining).
Using the Abgent sumoplot (http://www.abgent.com/sumoplot), as well as GPS-Sumo [23], we
determined that most of the mammalian sumoylation sites were not conserved in Ets96B.Drosoph-
ila Ets96B had a predicted site at lysine 429 (K429) with the sequence LKQD, and a site (K590)
possibly conserved with human PEA3-family members, having the sequence GKGD (Fig 1B, light
blue underlining). Whether or not these Ets96B sites are actually sumoylated is not known.
Differential gene expression in Ets96B knockdowns
Ets96B is highly expressed in the nervous system [19], therefore we knocked it down in all neu-
ronal cells throughout development, using the pan-neuronal elav-GAL4 driver [24] to express
UAS-Ets96BRNAi1 (Ets96BRNAi1) [25], and then performed SOLiD sequence analysis of the
entire transcriptome. By mapping the Drosophila transcriptome to the reference genome
obtained from flybase (build dmel_r5.47_FB2012_05), 15147 transcripts were identified,
including expressed genes (mRNA), miRNA, snRNA, snoRNA and tRNA (S1 Dataset). The
Drosophila gene Ets96B encodes two transcript variants (FBtr0084696 and FBtr0084697); how-
ever, the adult samples we sequenced expressed only FBtr0084696 (Ets96B-RC), which encodes
the Ets96B-PC protein isoform. Ets96B-PC is identical to Est96B-PB except for the extreme N-
terminus, where Ets96B-PB had a nine amino acid insert. In this experiment, 166 genes were
differentially expressed, taking into consideration the 'false discovery rate' and correcting for it
using Benjamini-Hochberg correction (S1 Dataset). We observed a complete lack of expression
of Ets96B in the experimental sample (S1 Dataset). To confirm the SOLiD result we performed
quantitative RT-PCR (qPCR) to measure the level of Ets96B transcript. Compared with con-
trols, Ets96B transcript levels were significantly lower in elav-GAL4;UAS-Ets96BRNAi1 males
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(P< 0.005) (Fig 2A). At this time we also checked Ets96B expression levels using a second
UAS-Ets96B RNAi line (Ets96BRNAi2) [25], transcript levels were also significantly lower in the
heads of elav-GAL4;UAS-ETS96BRNAi2 males (P< 0.005) (Fig 2A).
Fig 1. Comparison of Drosophila Ets96Bwith mammalian PEA3-family members (A) The evolutionary relationship was inferred using
the Maximum-likelihood method. The optimal tree with the sum of branch length = 3.794 is shown. The percentage of replicate trees in which
the associated taxa clustered together in the bootstrap test (5000 replicates) are shown next to the branches. The tree is drawn to scale, with
branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. (B) The protein sequences were
aligned and edited using CLC Sequence Viewer 6. Colors correspond to amino acid conservation (black = conserved, blue = no
conservation). The predicted ETS DNA binding domain is indicated by a dark blue underlining of amino acids near C-terminus. Human
sumoylation sites are indicated by black underlining; predicted Drosophila sumoylation site is indicated by light blue underlining.
doi:10.1371/journal.pgen.1006104.g001
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After performing pair-wise comparisons between all sequenced strains, 61 differentially
expressed genes remained significant (Table 1). Interestingly, most of these genes were up-reg-
ulated when Ets96B was knocked down in the CNS, with only 21% being down-regulated.
Using DAVID and KEGG, we categorized the differentially expressed genes by function [26,
27]. The largest group was involved in oxidative phosphorylation and redox reactions, with
32.8 percent of the genes falling into this category (Fig 2B). The next largest groups were a tie
between genes involved in lipid and sugar homeostasis, as well as those involved in translation,
Fig 2. Ets96B regulates genes involved in oxidative phosphorylation and redox reactions (A) Relative expression level of Ets96B in
5–7 day old control males or males where Ets96Bwas knocked down in the entire nervous system throughout development. This assay was
repeated at least 7 times. (n = 25 males per treatment; ** P<0.005 compared with controls, one-way ANOVA with Tukey’s post hoc test for
multiple comparisons). Error bars = SEM. (B) Pie chart showing KEGG classification of gene groups (percentage of total Ets96B up or down
regulated genes /percentage of all genes in the genome belonging to a particular category). (C) Drosophila genome depicting the location of
genes up (green) or down (red) regulated in Ets96B SOLiD sequencing of the entire Drosophila transcriptome.
doi:10.1371/journal.pgen.1006104.g002
Ets96BRegulates Dopaminergic Signalling
PLOS Genetics | DOI:10.1371/journal.pgen.1006104 June 9, 2016 5 / 33
Table 1. Solid sequencing data for up and down regulated genes in Ets96BRNAi versus all controls
Biological Process ID Gene Name Ets96BRNAi Expressed in CNS Human homologue
log2 (fold change) according to FlyAtlas
Lipid/sugar homeostasis
FBgn0029831 CG5966 -2,91 Yes PNLIP
FBgn0015575 α-Est7 -0,99 Yes
FBgn0032136 Apoltp -0,65 Yes
FBgn0037312 CG11999 3,36 Yes SDF2
FBgn0036549 CG10516 2,05 Yes SPSB3
FBgn0004654 Pgd 2,03 Yes PGD
FBgn0025885 Inos 1,29 Yes ISYNA1
FBgn0004045 Yp1 1,10 Yes
FBgn0001092 Gapdh2 0,75 Yes GAPDH
Translation
FBgn0028697 RpL15 -0,70 Yes RPL15
FBgn0000556 Ef1α48D -0,59 Yes EEF1A1
FBgn0010409 RpL18A 1,28 Yes RPL18A
FBgn0004404 RpS14b 1,13 Yes RPS14
FBgn0004867 RpS2 0,76 Yes RPS2
FBgn0003279 RpL4 0,66 Yes RPL4
FBgn0036213 RpL10Ab 0,64 Yes RPL10A
FBgn0005593 RpL7 0,63 Yes RPL7
FBgn0000100 RpLP0 0,58 Yes RPLP0
Amino acid metabolism
FBgn0037146 CG7470 -1,51 Yes ALDH18A1
FBgn0002565 Lsp2 3,91 Yes
FBgn0022774 Oat 2,26 Yes OAT
FBgn0000150 awd 1,36 Yes NME1-NME2
FBgn0000116 Argk 0,76 Yes CKB
Oxidation reduction
FBgn0023507 CG3835 -1,53 Yes D2HGDH
FBgn0030041 CG12116 -1,22 Yes
FBgn0031689 Cyp28d1 -1,11 Yes
FBgn0000406 Cyt-b5-r -1,06 Yes
FBgn0025678 CaBP1 3,24 Yes CABP1
FBgn0033663 ERp60 2,57 Yes PDIA3
FBgn0013685 mt:ND6 2,13 Yes ND6
FBgn0013684 mt:ND5 1,57 Yes ND5
FBgn0013680 mt:ND2 1,38 Yes ND2
FBgn0013675 mt:CoII 1,30 Yes COX2
FBgn0086254 CG6084 1,29 Yes AKR1B15
FBgn0013678 mt:Cyt-b 1,26 Yes CYTB
FBgn0016691 Oscp 1,16 Yes ATP5O
FBgn0013672 mt:ATPase6 1,11 Yes ATP6
FBgn0020236 ATPCL 1,00 Yes ACLY
FBgn0010100 Acon 0,98 Yes ACO2
FBgn0013674 mt:CoI 0,96 Yes COX1
FBgn0024289 Sodh-1 0,96 Yes SORD
FBgn0000055 Adh 0,76 Yes ADH1
FBgn0013676 mt:CoIII 0,74 Yes COX3
(Continued)
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each contained 14.7% of the genes (Fig 2B). Next, we mapped the differentially expressed
genes to identify if they were enriched in any particular chromosomal region (Fig 2C). From
this map it was evident that genes affected by loss of Ets96B were distributed throughout the
genome.
Ets96B inhibits the expression of a conserved molecular chaperone
complex
Using a ±log2 change in expression of 2.5 as a cut-off, we investigated the genes most highly
affected when Ets96B was knocked down in the entire nervous system throughout development
(Fig 3A). We utilized STRING and BioGrid [28, 29] to find interacting proteins for these top
hits, however, it was immediately evident that three of them interacted: Calcium-binding pro-
tein 1 (CaBP1), Calreticulin (Crc), and ERp60.
To confirm the SOLiD sequencing results we picked CaBP1, Crc and ERp60 and performed
qPCR analysis (Fig 3B). The level of expression in elav-GAL4 heterozygous controls was set as
100%, represented as 1 on the graph (Fig 3B). Compared to either elav-GAL4+/- or Ets96BRNAi1+/-
controls, Ets96BRNAi1 knockdown flies had a significant increase in CaBP1 (P< 0.005), ERp60
(P< 0.005) and Crc (P< 0.005) expression (Fig 3B). This was similar to results obtained by
SOLiD sequencing (Fig 3A).
It was reported that overexpression of an RNAi can lead to saturation of the RNA-induced
silencing complex (RISC), leading to neuronal cell death or stress [30, 31]. Therefore, we per-
formed a control experiment overexpressing GFP under the control of elav-GAL4 and then
used two different GFP RNAi lines to inhibit GFP expression (Figs 1A and S3). We then
Table 1. (Continued)
Biological Process ID Gene Name Ets96BRNAi Expressed in CNS Human homologue
log2 (fold change) according to FlyAtlas
Protein processing
FBgn0033366 Ance-4 -1,31 Yes
FBgn0005585 Crc 2,75 Yes CALR
FBgn0001233 Hsp83 2,19 Yes HSP90AB1
FBgn0036015 CG3088 1,99 Yes
FBgn0039562 Gp93 1,27 Yes HSP90B1
FBgn0024352 Hop 2,06 Yes STIP1
FBgn0023529 CG2918 1,37 Yes HYOU1
Immune defense
FBgn0030262 Vago -1,78 Yes
FBgn0010225 Gel -0,58 Yes
FBgn0044812 TotC 3,71 Yes
FBgn0012042 AttA 2,75 Yes
FBgn0028396 TotA 1,43 Yes
FBgn0035290 CG1887 1,16 No
FBgn0022355 Tsf1 0,97 Yes
FBgn0016687 Nurf-38 0,93 Yes PPA2
Neuropeptide hormone signaling
FBgn0037290 CG1124 1,35 Yes
FBgn0027586 CG5867 0,96 Yes
FBgn0042201 Nplp3 0,81 Yes
doi:10.1371/journal.pgen.1006104.t001
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Fig 3. Ets96B regulates a conserved molecular chaperone complex. (A) SOLiD data for elav-
GAL4>Ets96BRNAi versus controls (w, elav-GAL4>w1118 andw1118> Ets96BRNAi) 5–7 day old male heads.
Only genes regulated more than ±log2 2.5-fold change are included. (B) Relative expression levels of
CaBP1, ERp60 andCrc in 5–7 day old control males or males where Ets96Bwas knocked down in the entire
nervous system throughout development. This assay was repeated at least 7 times. Error bars indicate SEM.
(n = 25 males per treatment; *** P<0.005 compared with elav-GAL4 controls, one-way ANOVA with Tukey’s
post hoc test for multiple comparisons). (C) Biogrid and String were used to find all genes that interact with
the molecular chaperone genes recovered in the Ets96B knockdownmales. Genes in red were recovered in
the Ets96B SOLiD sequencing. (D) Data showing human homologues of Drosophila genes recovered in
Biogrid and String analysis. Genes in red were recovered in the Ets96B SOLiD sequencing. (E) Diagram
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measured the level of expression of CaBP1, ERp60 and Crc; no differences in the expression lev-
els of CaBP1, ERp60 and Crc were observed between controls and GFP knockdown males (Figs
1B and S3).
When looking at interacting genes, we noticed that Crc networked in both STRING and
BioGRID with another hit from the SOLiD sequence data, Glycoprotein 93 (Gp93, human
HSP90B1), which in turn interacted with yet another hit, CG2918 (human HYOU1) (Table 1).
Utilizing these genes, and all the genes with which they were predicted to interact, we employed
the STRING program to make a network (Fig 3C). From this it was evident that the genes
formed a network, with Gp93, Protein disulfide isomerise (Pdi), and CaBP1 identified as hubs
(Fig 3C).
All of the genes used to make the interaction map had human homologues (Fig 3D). These
proteins locate to the ER and are involved in the regulation of protein folding (Fig 3E). Of note,
all homologous genes in this pathway that were highly overexpressed when Ets96B was
knocked down in the CNS, are involved in disulphide bridge formation (Crc, ERp60 and
CaBP1) (Fig 3E, proteins marked in red and underlined).
Ets96B affects starvation resistance
Given that knocking down Ets96B affected genes involved in energy homeostasis (mitochon-
drial electron transport chain, Table 1) and protein production (Fig 3E), as well as inhibited
the expression of CG5966 (Drosophila homologue of human pancreatic lipase, PNLIP), we
wanted to understand if loss of Ets96B had any effect on metabolism. Furthermore, to deter-
mine if Ets96B had a developmental phenotype, both the pan-neuronal elav-GAL4 driver and
the Ets96B-GAL4 driver [32] were employed. Ets96B is located on the right arm of the third
chromosome at 96A22 in the forward orientation and encodes for two isoforms (S1 Fig).
Recently, a 832 bp region from the third intron of Ets96B-RB, or fourth intron of Ets96B-RC,
was cloned and used to make a GAL4 transgenic line (GMR36H05-GAL4, which we refer to as
Ets96B-GAL4) [32] (S1 Fig).
To begin, we performed a starvation assay utilizing the Drosophila Activity Monitoring Sys-
tem (DAMS), as it is able to uncover broad defects in metabolism [33]. Knocking down Ets96B
in the entire CNS during development using either Ets96BRNAi1 or Ets96BRNAi2 made flies more
susceptible to starvation (P< 0.005) (Fig 4A). A similar phenotype was observed when Ets96B
was knocked down throughout development using the Ets96B-GAL4 driver (P< 0.005) (Fig
4A). To clarify if this was indeed a developmental phenotype, we used the elav-Gal4,tubGal80ts
driver [34] to knockdown Ets96B specifically in adults using either Ets96BRNAi1 or Ets96BRNAi2.
Remarkably, this induced the opposite phenotype, where males were significantly more resis-
tant to starvation than controls (P< 0.01) (Fig 4A).
To establish if Ets96B transcript levels in the brain were regulated by starvation, we per-
formed qPCR analysis on heads from adult males starved for either 24h or 48h. Starving males
for 24h significantly increased Ets96B expression (P< 0.01) (Fig 4B). Additionally, we deter-
mined if macronutrient content influenced Ets96B expression. Transcript levels of males fed a
control diet (10 g/dl:10 g/dl sucrose:brewer’s yeast) were set as 100%, represented as 1 on the
graph (Fig 4C). However, none of the diets had a significant effect on Ets96B expression.
depicting molecules involved in endoplasmic reticulum protein folding. These include molecular chaperones
that function to prevent aggregation (Bip, HSP90B1, DNAJC3, HYOU1 and CALR), protein disulfide
isomerases that catalyze disulfide bond formation, isomerization and reduction (PDIA3, PDIA3 and P4HB),
and proteins involved in de- or re-glycosylation of improperly folded glycoproteins (PRKCSH and UGGT1).
Drosophila homologues that were up-regulated when Ets96Bwas knocked down are in red, and those that
were up-regulated more than 2.5-fold are underlined.
doi:10.1371/journal.pgen.1006104.g003
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Ets96B affects lipid storage
Given that starvation resistance was affected in Ets96B knockdown males, to understand if
Ets96B regulates normal feeding behaviour a CAFE assay was performed to measure how
much food flies fed ad libitum consumed during a 24h period [35]. There was no significant
difference in the amount of food consumed when Ets96B was knocked down in the nervous
system by expressing Ets96BRNAi1 throughout development (S2 Fig). We also performed the
CAFE assay using the elav-Gal4,tubGAL80ts driver to knockdown Ets96B specifically in adults.
Again no significant difference was observed between Ets96B knockdown flies or controls (S2
Fig). Perhaps these are not surprising results, given that our SOLiD data revealed no significant
change in the expression of any gene known to directly influence feeding behaviour (Table 1
and S1 Dataset).
Next, we determined the stored lipid content before and during starvation. For this we mea-
sured triacylglyceride (TAG) levels in normal fed flies, as well as during starvation. Interest-
ingly, the lipid content of elav-GAL4;UAS-Ets96BRNAi1 or elav-GAL4;UAS-Ets96BRNAi2
Fig 4. Ets96B regulates starvation resistance. (A) We tested the effect of Ets96B-knockdown in flies using the starvation survival assay.
5–7 day old control and Ets96B knockdownmales (GAL4 driver crossed to either Ets96BRNAi1 or Ets96BRNAi2) were placed in a vial containing
1% agarose and maintained at 25°C. DAMS was used to monitor activity. (n = 30–60 flies per genotype, one-way ANOVA with Tukey’s post
hoc test for multiple comparisons) (B) To examine how starvation affects the expression level of Ets96B, RNA was extracted from normal fed
flies, as well as after 24 and 48 h of starvation. (C) To examine how nutritional state affects the expression levels of Ets96B, RNA was
extracted under different nutritional states. Flies fed ad lib were set as 100%, represented by 1 on the graphs (B, C: n = 10 replicates, one-way
ANOVA with Tukey’s post hoc test for multiple comparisons) (D, E) Triglyceride levels were determined in male flies at 0, 12 and 24 hours of
starvation. The (D) elav-Gal4 driver was used to express Ets96B RNAi (Ets96BRNAi1 or Ets96BRNAi2) throughout development (UAS-
Ets96BRNAi1 and UAS-Ets96BRNAi2) and (E) the elav-GAL4,tub-GAL80ts driver was used to knockdown Ets96B (Ets96BRNAi1 or Ets96BRNAi2)
in adult males. (D, E: n = 30 males per treatment, assay was repeated at least 10 times for each genotype, one-way ANOVA with Tukey’s post
hoc test for multiple comparisons). In all graphs significance levels are indicated: *, P<0.05; **, P<0.01; ***, P <0.005. Error bars = SEM.
doi:10.1371/journal.pgen.1006104.g004
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knockdown males was significantly higher than either control (P< 0.005) (Fig 4D). After 12h
and 24h of starvation all strains had lower total TAG levels and there was no significant differ-
ence between strains (Fig 4D). This suggests that during the first 12h of starvation, Ets96BRNAi
knockdown males mobilized more of their stored lipids than control flies.
Next, using the elav-Gal4,tubGal80ts driver, we knocked down Ets96B specifically in adults.
Similar to the starvation assay, this induced the opposite phenotype, where the TAG content of
Ets96BRNAi1 or Ets96BRNAi2 knockdown males was significantly lower than either control
(Ets96BRNAi1 P< 0.01, Ets96BRNAi2 P< 0.05) (Fig 4E). As before, after 12h and 24h of starva-
tion all strains had lower lipid contents and there was no significant difference between strains
(Fig 4E). Contrary to knocking down Ets96B throughout development, when Ets96B was
knocked down specifically in the adult nervous system, males mobilized significantly less of
their lipid stores during the first 12h of starvation.
Even though knocking down a random gene, such as EGFP, in the nervous system had no
effect on the Ets96B-regulated molecular chaperones, CaBP1, ERp60 or Crc, we still wanted to
confirm that activating the RNAi system in the CNS didn’t induce unspecific phenotypes.
Therefore, we measured triacylglyceride (TAG) levels in normal fed flies, as well as during star-
vation; of controls (elav-GAL4;UAS-GFP) and GFP knockdown males, no differences in TAG
levels were observed (Figs 3C and S3).
Ets96B regulates startle-response and sleep
One of the molecular chaperones upregulated when Ets96B was knocked down in the nervous
system, Crc, is necessary for startle-induced locomotion. Yamamoto et al. [36] reported that
Crcmutants lack a startle-response. Therefore, we hypothesized that Ets96B knockdown males,
where Crc is overexpressed (see Fig 3A and 3B), would have the opposite phenotype and be
excessively responsive to being startled. Using the same assay [36], we found that knocking
down Ets96B in the nervous system throughout development induced a heightened startle-
response (P< 0.01) (Fig 5A). When Ets96B was knocked down specifically in adults the star-
tle-response was the same as control males (P = 0.57) (Fig 5B).
Ets96B was further assessed for behavioural defects using a DAMS movement based assay.
During the first hour in the DAMS knocking down Est96B (Ets96BRNAi1 or Ets96BRNAi2), using
either elav-GAL4 or Ets96B-GAL4, had significantly more movement than controls (P< 0.01,
except Ets96B-GAL4;UAS-Ets96BRNAi1 P< 0.005) (Fig 5C) This hyperactivity continued dur-
ing the second hour in the DAMS (P< 0.05) (Fig 5C). The activity level of all genotypes was
similar throughout the last two hours monitored. Furthermore, during the first 30 minutes
after light shock, both elav-GAL4;UAS-Ets96BRNAi and Ets96B-GAL4;UAS-Ets96BRNAi knock-
down males, using either Ets96BRNAi1 or Ets96BRNAi2, had significantly more movement than
either control (P< 0.01, except elav-GAL4;UAS-Ets96BRNAi1 P< 0.05), but not 30 minutes
prior to or 30–60 minutes after light shock (Fig 5D). This indicates that knocking down Ets96B
in the nervous system during development increased exploration/anxiety when the setting was
novel, as well as after a light-shock stimulus.
Next, to check that the DAMS measured response was not specific for light-shock stimulus,
we repeated the assay using a loud white noise (65-70dB) to induce stress. Similar to what was
observed with light-stimulus, during the first 30 minutes after noise shock, elav-GAL4;
UAS-Ets96BRNAi1 knockdown males had significantly more movement than either control
(P< 0.005), but not 30 minutes prior to or 30–60 minutes after light shock (Fig 5E)
Finally, to check for any general effects on the neurons due to overexpression of an RNAi,
we again expressed GFP under the control of elav-GAL4 and used two different GFP RNAi
lines to inhibit GFP expression. We then tested these males in the DAMS for any effect on the
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startle-response. Similar to what was observed in the TAG assay, general overexpression of an
RNAi in the entire nervous system had no effect on the startle-response (Figs 3D and S3).
In addition, we employed the DAMS to determine if there was an effect on general activity
and sleep/wake behaviour (Fig 6A). To measure locomotor activity, male flies were placed in
the DAMS and activity was quantified every minute for a 24h period. When Ets96B was
knocked down using either the elav-GAL4 (P < 0.01) or Ets96B-GAL4 (P < 0.01) driver,
males were significantly more active (Fig 6B). When Ets96B was knocked down specifically
in adults, activity was similar to controls (P = 0.58 compared to elav-Gal4,tubGal80ts hetero-
zygous control) (Fig 6C). We also observed that elav-GAL4> Ets96BRNAi knockdown flies
(Ets96BRNAi1 or Ets96BRNAi2) slept significantly less during the night than controls (Fig 6A
and 6D). When Ets96B was specifically knocked down in adults there was no difference in
sleep/wake behaviour between knockdown males and controls (Fig 6E, only Ets96BRNAi1
used for this experiment).
Fig 5. Ets96B knockdown during development induces a heightened startle-response. (A, B) Startle-response test
demonstrating Ets96B knockdown males have a hyperactive startle-response. (A) Ets96B knocked down throughout
development using UAS-Ets96BRNAi1 or UAS-Ets96BRNAi2 crossed to the pan-neuronal driver elav-GAL4 (B) Ets96B knocked
down only in adults using UAS-Ets96BRNAi1 crossed to the pan-neuronal driver and temperature sensitive allele of the GAL4
inhibitor GAL80 elav-GAL4, tub-Gal80ts. (A, B: n = 50 males per strain; ** P<0.01 compared with controls, one-way ANOVA with
Tukey’s post hoc test for multiple comparisons). (C) The DAMS system was used to monitor locomotion for the first four hours flies
were placed in the system. (D) The DAMS system was used to monitor locomotion prior to and after light stimulation. (E) The
DAMS system was used to monitor locomotion prior to and after sound stimulation (65–70 dB). Only Ets96BRNAi1 was used for this
assay. (C-E: n = 30–60 males per strain; * P < 0.05, ** P<0.01, *** P < 0.005 compared with controls, one-way ANOVA with
Tukey’s post hoc test for multiple comparisons) In all graphs error bars = SEM.
doi:10.1371/journal.pgen.1006104.g005
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Drosophila Ets96B and mouse Etv5 are expressed in dopaminergic
neurons
Next, to see where Ets96B could be involved in nervous system signalling we crossed Ets96B-
GAL4 toUAS-GFP and mapped GFP expression in the adult brain. Since dopamine is known to
be a major regulator of the startle-response, we co-stained the brains for Tyrosine hydroxylase
Fig 6. Ets96B regulates activity and sleep/wake behaviour. The DAMS system was used to monitor locomotion and sleep/wake
behaviour over a 48 hour period. (A) Bar diagram indicating general activity over a 48 hour period of adult flies maintained on a 12:12 hour
light:dark cycle. White bar indicates lights-on and dark bar and gray highlight indicate lights-off. Representative result for one run using
Ets96BRNAi1 is shown (B) Total number a beam breaks over a 24 hour period in control flies or flies were Ets96B was knocked down
(Ets96BRNAi1 or Ets96BRNAi2) throughout development either in the entire nervous system (elav-GAL4) or specifically in Ets96B neurons
(Ets96B-GAL4). (C) Total number a beam breaks over a 24 hour period in control flies or flies were Ets96B was knocked down
(Ets96BRNAi1) specifically in adult neurons (elav-GAL4;tubGAL80ts). (D) Total minutes flies slept per night in control flies or flies were
Ets96B was knocked down (Ets96BRNAi1 or Ets96BRNAi2) throughout development, either in the entire nervous system (elav-GAL4) or
specifically in Ets96B neurons (Ets96B-GAL4). (E) Total minutes flies slept per night in control flies or flies were Ets96B was knocked down
(Ets96BRNAi1) specifically in adult neurons (elav-GAL4;tubGAL80ts). (B-E, n = 30–60 males per strain; * P < 0.05, ** P<0.01 compared with
controls, one-way ANOVAwith Tukey’s post hoc test for multiple comparisons) In all graphs error bars = SEM.
doi:10.1371/journal.pgen.1006104.g006
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(TH), which is necessary for the production of L-DOPA and specifically marks dopaminergic
neurons [37]. Interestingly we saw that Ets96B was almost exclusively expressed in dopaminergic
neurons (Fig 7A–7C). Specifically, we saw Est96B-GAL4 induced GFP expression in the suboe-
sphageal ganglionic (SOG) region in the brain (Fig 7A and 7B). Furthermore, Est96B-GAL4
induced GFP-expression co-localized with TH in a subset of dopaminergic PPM1/2 neurons (Fig
Fig 7. Ets96B and Etv5 expressed on dopaminergic neurons. (A-C) Ets96B-GAL4was crossed to UAS-GFP to
examine Ets96B expression in adult male brains. Adult male brains were then stained for GFP and Tyrosine
hydroxylase (TH) expression. (A) Anterior section showing co-expression of GFP and TH in the eye, the ventrolateral
prototcerebrum (VLP and the suboesophageal ganglion (SOG, see inset). (B) Midbrain, no co-expression was
observed in the dopaminergic clusters PAM or PAL, while coexpression was observed in the SOG (see inset). (C) In
the posterior brain section no co-expression was observed in dopaminergic clusters PPL1 or PPL2, but there was co-
expression of GFP and TH in cluster PPM1/2 (see inset). There were also two neurons near the dopaminergic PPM1/2
cluster that were GFP specific, and had no TH expression (see inset, white arrow). In A-C size bar is equivalent to
100 μm. (D-G) Black scale bar, 1mm. (H-P) white scale bar, 0.5 mm. Bregma levels and described brain regions are
according to Allen Mouse Brain Atlas. (H, I) Cortex layers 1–6. (J) basolateral amygdaloid nucleus, anterior part (BLA),
basolateral amygdaloid nucleus, ventral part (BLV), basomedial amygdaloid nucleus, posterior part (BMP), central
nucleus of amygdala, lateral part (CeL), dorsal endopiriform claustrum (DEn), stria medullaris (STIA), ventral
endopiriform claustrum (VEn), (K) ventromedial thalamic nucleus (VM), (L) dorsomedial hypothalamic nucleus, ventral
part (DMV), nigrostriatal tract (ns), ventromedial hypothalamic nucleus, central part (VMHC), ventromedial
hypothalamuc nucleus, dorsomedial part (VMHDM), ventromedial hypothalamic nucleus, ventrolateral part (VMHVL),
(M) Cortex layers 1–6, (N) parabrachial pigmented nucleus of the VTA (PBP), ventral tegmental area (VTA), (O) field
CA1 of the hippocampus (CA1), field CA2 of the hippocampus (CA2), field CA3 of the hippocampus (CA3), lacunosum
moleculare layer of the hippocampus (LMol), pyramidal layer of the hippocampus (Py), (P) crus 1 of the ansiform lobule
(Crus1), lobule 4 and 5 of the cerebellar vermis (4/5Cb).
doi:10.1371/journal.pgen.1006104.g007
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7C). Interestingly, within the PPM1/2 neurons there were two neurons that were GFP positive
but TH negative (Fig 7C, inset, white arrows). There was also a strong overlap between Ets96B-
GAL4 driven GFP and TH in the eye and the ventrolateral protocerebrum (VLP) (Fig 7A).
Although GAL4 driven GFP is not an entirely reliable source for mapping gene expression, this
result is an indication that Ets96Bmay be expressed in the regions of theDrosophila brain gov-
erning locomotion, as well as odour and visual-driven memory and learning. Furthermore, the
Ets96B-GAL4 driver may not recapitulate the entire Ets96B expression pattern.
In order to specify if the expression pattern of Etv5 was enriched in dopaminergic-rich
regions of the mouse brain, we performed detailed mRNA in situ hybridization mapping on
coronal sections (Fig 7D–7G, S1 Table). Etv5mRNA was expressed in a specific and distin-
guishable pattern in certain brain regions, predominantly the cerebral cortex (Fig 7H, 7I and
7M), the amygdala (Fig 7J), and the hypothalamus (Fig 7L). Within the cerebral cortex there
was conspicuously high expression in cortical layers 2, 4 and 6, while expression was almost
absent from layers 1, 3, and 5 (Fig 7H, 7I and 7M). Furthermore, high expression was also
observed in the dorsal and ventral endopiriform claustrum (Fig 7J). Strong expression was
observed in limited parts of the amygdale, including the basolateral amygdaloid nucleus, ven-
tral part (Fig 7J). Considerably high expression was found in the bed stria terminalis and the
central amygdaloid nucleus (Fig 7J). Etv5 expression was observed at low to moderate levels in
the hypothalamus, whereas expression was almost absent in the thalamus (Fig 7K and 7L). In
conclusion, hypothalamic expression was found in the dorsomedial hypothalamic nucleus and
also the central, dorsomedial and ventrolateral part of the ventromedial hypothalamic nucleus
(Fig 7L). Strong expression was also identified in the nigrostriatal tract (Fig 7L). In the mesen-
cephalon expression was restricted to the ventral tegmental area (VTA), including the parabra-
chial pigmented nucleus of the VTA (Fig 7N). In the hippocampus, Etv5 was strongly
expressed in the pyramidal cell layer, CA1 through CA3. Some expression was also found in
the lacunosum moleculare layer (Fig 7O). Low levels of Etv5mRNA expression were observed
in the cerebellum, including the Granular, Molecular and Purkinje cell layers (Fig 7P). Other
regions in the brain are listed in S1 Table.
Ets96B required in dopaminergic neurons for proper metabolism and
behaviour
Given that Ets96B and mouse Etv5 seemed to be expressed in dopaminergic-rich regions, we
used the ple-GAL4 driver (pale [ple] is the Drosophila tyrosine hydroxylase, necessary to con-
vert tyrosine to L-DOPA) to knockdown Ets96B transcript specifically in dopaminergic neu-
rons throughout development. We then examined the transcription levels of a select number of
genes-ple, Vesicular monoamine transporter (Vmat), and Dopamine transporter (DAT)-known
to influence dopamine production, release or reuptake (Fig 8A–8C). Transcription levels of the
ple-GAL4 heterozygous controls were set at 100%, shown as 1 on the various graphs. When
Ets96B expression was knocked down in dopaminergic neurons, the transcript level of ple was
significantly upregulated (P< 0.005) (Fig 8A). Furthermore, the expression of Vmat, involved
in the transportation of monoamines such as dopamine into the synaptic vesicles, was also
increased in Ets96B knockdown males (P< 0.05) (Fig 8B). Finally, the expression of DAT,
which is necessary to pump dopamine out of the synapse back into cytosol, was significantly
lower when Ets96B expression was knocked down in dopaminergic neurons (P< 0.005) (Fig
8C). Increased dopamine production and decreased dopamine reuptake should lead to pro-
longed dopamine signalling.
Next, we asked if knocking down Ets96B specifically in dopaminergic neurons was sufficient
to recapitulate the starvation and startle-response phenotypes. Similar to what was observed
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using the elav-GAL4 and Ets96B-GAL4 drivers, knocking down Ets96B specifically in dopami-
nergic neurons throughout development made adult males more susceptible to starvation
(P< 0.01) (Fig 8D). Furthermore, lowering Ets96B transcript levels in dopaminergic neurons
was sufficient to replicate the heightened light-induced startle-response (P< 0.005) (Fig 8E).
To determine if the increased startle-response observed when Ets96B was knocked down spe-
cifically in dopaminergic neurons was due to increased dopamine signalling, we fed adult
males the tyrosine hydroxylase inhibitor 3-iodo-L-tyrosine before performing the light-
induced startle-response assay. In controls this was sufficient to abolish the light-induced star-
tle-response (Fig 8E). In males where Ets96B was knocked down in dopaminergic neurons,
inhibiting dopamine production reduced the startle-response to the same level as normal fed
controls (Fig 8E). From this result we conclude that reducing Ets96B expression in dopaminer-
gic neurons increases dopamine signalling.
Fig 8. Ets96B required in dopaminergic neurons. (A-C) Ets96Bwas knocked down throughout
development (Ets96BRNAi1 or Ets96BRNAi2) specifically in dopaminergic neurons using the ple-GAL4 driver
and the transcript level of genes (A) ple, (B) Vmat and (C) DAT was measured. RNA was collected from the
heads of 5- to 7-day-old males for each genotype. qPCR was repeated at least 7 times for each transcript.
(n = 25 males per treatment; * P<0.05, *** P<0.005 compared with controls, one-way ANOVA with Tukey’s
post hoc test for multiple comparisons) (D) Ets96Bwas knocked down throughout development (Ets96BRNAi1
or Ets96BRNAi2) specifically in dopaminergic neurons using the ple-GAL4 driver. 5–7 day old control and
Ets96B knockdown males were placed in a vial containing 1% agarose and maintained at 25°C, DAMSwas
used to monitor activity. (n = 30–60 flies per genotype, ** = P < 0.01, one-way ANOVA was used to
determine significance with Tukey’s post hoc test for multiple comparisons). (E) The DAMS system was used
to monitor locomotion prior to and after light stimulation. Only Ets96BRNAi1 was used for this assay. (n = 30
males per strain; * P<0.05, *** P<0.005 compared with controls, Kruskal-Wallis non-parametric ANOVA was
used to determine significance). In all graphs error bars = SEM.
doi:10.1371/journal.pgen.1006104.g008
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Human ETV5 SNPs link to BMI and Bipolar disorder
The startle-response phenotype demonstrated by loss of Ets96B in the nervous system is similar
to the effect of prepulse inhibition (PPI) in mammals. PPI is a neurological phenomenon
where a weaker prestimulus (prepulse) inhibits the reaction to a subsequent stronger startle
stimulus (pulse). In humans disrupted PPI responses are linked with bipolar disorder [38].
Using the GWAS Central database [39] we searched for ETV5 localized SNPs that had a signifi-
cant link (P< 0.05) to either BMI or bipolar disorder. Employing this method we found 12
SNPs mapped to ETV5 that significantly linked to BMI (S2 Table). Interestingly, three of these
SNPs were also significantly linked to bipolar disorder (S2 Table). Next, we made a map to
define where these 12 SNPs localized within the ETV5 genomic region (Fig 9A). Of notable
interest, the three BMI/bipolar associated SNPs all localized around ETV5 exons 6 and 7 (Fig
9A, blue highlighted SNPs). This is an interesting genetic region as there is evidence a truncated
ETV5 transcript is produced that stops after exon 7, which would encode only the inhibitory
N-terminal PEA3 domain [40]. Furthermore, this same region encoded a long non-coding
antisense RNA (lncRNA) called ETV5-AS1 (Fig 9A). Using the NONCODE database [41] we
determined that ETS5-AS1 was expressed in the adrenal glands, testis and thyroid.
Using Encode Roadmap {http://www.encode-roadmap.org/} (S4 Fig) and RegulomeDB [42]
(Table 2) databases we determined the methylation state of the ETV5 gene in various brain
regions. By means of these databases we found that SNPs rs7647305 and rs1356292 mapped to
the promoter region. In fact, rs7647305 was predicted to map to the TATA-box and rs1356292
was predicted to be at the transcription start site (Table 2). It was interesting that rs4686730
was predicted to map to an insulin promoter factor 1 (IPF1) binding site (Table 2), considering
that Etv5 was found to be necessary for the secretion of insulin in mice [43]. When examining
the chromatin state of the three SNPs linked to BMI and BD, (rs4686730, rs7433760 and
rs4686728) they were all quiescent in the brain germinal matrix (BGM) (Table 2). Further-
more, in brain regions known to control reward response, such as the anterior caudate (BAC)
and midfrontal lobe (BMFL), rs7433760 mapped near a region with H3K4 single methylation,
indicating an active enhancer (S4 Fig). In the RegulomeDB database, rs7433760 was predicted
to map to an active enhancer in the angular gyrus (BAG), dorsolateral prefrontal cortex
(BDPF) and the hippocampus middle (BHM), areas involved in decision making and memory.
Finally, we made a linkage disequilibrium map that demonstrated tight linkage between all
ETV5 SNPs linked to BMI and BD, except for BMI-linked rs6777779 (Fig 9B).
Next we wanted to determine if the human homologues of the Drosophila ER molecular
chaperones (Fig 3D), whose expression is regulated by Ets96B, also linked to BMI and BD.
Using data from multiple GWAS studies (BMI, Waist-hip ratio or bipolar disorder [8, 44–46])
we searched for SNPs localizing to the human ER molecular chaperone homologues. We found
SNPs with a significant link (P< 0.05) to either BMI or BD that localized to three of the homo-
logues (PDIA3, PDIA6 and HYOU1) (Fig 10A). We located 9 SNPs mapped to PDIA3, 5 SNPS
mapped to PDIA6 and 5 SNPS mapped to HYOU1 that significantly linked to BMI. Further-
more, we found 1 SNP mapped to PDIA3, 3 SNPs mapped to PDIA6 and 3 SNPs mapped to
HYOU1 that significantly linked to BD (Fig 10A). Next, we made linkage disequilibrium maps
for PDIA6 andHYOU1 that demonstrated tight linkage between all PDIA6 SNPs linked to BD
(Fig 10B); the same was true for HYOU1, except for BD-linked rs511134 (Fig 10C).
Discussion
We knocked down the Drosophila ETV5 homolog Ets96B in neurons and discovered that it reg-
ulates expression of genes involved in the mitochondrial electron transport chain (See Table 1),
as well as endoplasmic reticulum localized molecular chaperones. Furthermore, we observe
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Fig 9. Human ETV5 SNPs associated with bodymass index and bipolar disorder. (A) Localization of
relevant single nucleotide polymorphisms (SNPs) in the ETV5 gene. SNP names according to NCBI dbSNP.
The GWAS central database was used to link ETV5 associated SNPS to BMI. Interestingly, three SNPs were
also associated with bipolar disorder (blue SNPs). The three bipolar-linked SNPs all localize around exons 6
and 7, which is also the location of the long, noncoding RNA (lncRNA) ETV5-AS1. Snap Proxy was then used
to determine Pair-linked disequilibrium in various populations. (B) Linkage disequilibrium between SNPs in
ETV5. Black boxes = exons, thick black lines between boxes = introns, red points = SNPs associated with
BMI in GWAS, blue points = SNPs associated with bipolar disorder in GWAS. The LD between SNPs in the
CEU population is expressed as R2 and displayed as a color code below the plot.
doi:10.1371/journal.pgen.1006104.g009
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that loss of Ets96B affects starvation resistance, lipid storage, startle-response and sleep/wake
behaviour. Moreover, knocking down Ets96B specifically in dopaminergic neurons influences
the expression of genes involved in dopamine signalling, and is sufficient to recapitulate both
metabolic and behavioural phenotypes. Finally, we map human ETV5-associated SNPs linked
to BMI and bipolar disorder to a location surrounding ETV5 exons 6 and 7. This region is
interesting as it may be involved in regulating the expression of a truncated ETV5 protein,
comprising only the PEA3 inhibitory domain [40]. This same region also contains a long non-
coding RNA (lncRNA), ETV5-AS1, whose function is unknown at this time; however, there is
evidence that lncRNAs regulate alternative splicing [47].
The involvement of ETV5 homologues in the development and maintenance of the dopami-
nergic system has been studied previously [48–50]. The first evidence of an ETV5 homologue
regulating dopaminergic neuronal development was discovered in C. elegans, where loss of ast-
1 resulted in the failure of dopaminergic neurons to develop [48]. Subsequently, dopaminergic
neuronal development in the substantia nigra (SN) and ventral tegmental area (VTA) of Etv5
knockout mice was studied. In Etv5 knockout mice, within the studied regions the dopaminer-
gic system developed normally and there was no significant difference observed in genes that
regulate dopamine signalling, such as dopamine transporter (Dat) or vesicular monoamine
transporter 2 (Vmat2) [49]. Our study demonstrates that Etv5 is extensively expressed through-
out the mouse brain (see Fig 7G–7P). One region where we observed high levels of Etv5 expres-
sion, the amygdala (see Fig 7J), was not studied in Wang and Turner [49]. Interestingly, in
mice dopaminergic neurons within the amygdala have been shown to regulate both anxiety
and depressive-like behaviours [51, 52]. There is a possibility that Etv5 function in the regula-
tion of dopaminergic neuronal development or maintenance is more important in areas other
than the SN or VTA, such as the amygdala. Given that we show that Drosophila Ets96B regu-
lates genes involved in cellular stress, in mice Etv5 might only become important in dopami-
nergic neurons when they come under stress. These possibilities should be followed up in
Table 2. Regulatory elements and chromatin states associated with ETV5 SNPs.
Histone Modiﬁcations/Chromatin State
rsID Bound Protein/Motifs BAG BAC BCG BDPF BGM BHM BITL BSN FB-F FB-M
rs9816226 ND ND ND ND ND ND ND ND ND ND ND
rs7647305 Pit1, Tbp Q/L WRPC Q/L Q/L WRPC WT Q/L WT Q/L WRPC
rs1356292 None FATSS FATSS FATSS FATSS FBTSS FATSS ATSS E ATSS FSTSS
rs1516726 ND ND ND ND ND ND ND ND ND ND ND
rs1516725 GR WT WT WT WT RPC E WT WT WT WRPC
rs4234589 FOX WT WT WT WT WT WT WT WT E FATSS
rs6809651 ND ND ND C ND ND ND ND ND ND ND
rs4686730 MAX/ER, c-Myb, OPF1. TGIF1 WT WT WT WT Q/L WT WT WT Q/L WT
rs7433760 None E WT WT E Q/L E WT WT Q/L WT
rs4686728 None WT WT WT WT Q/L WT WT WT WT WT
rs6777779 ND ND ND ND ND ND ND ND ND ND ND
rs9824882 HNF3beta, Oct1, Fox WT WT ST WT WT ST ST WT WT St
Abbreviations: POU domain, class 1, transcription factor 1 (Pit1), TATA-binding protein (Tbp), glucocorticoid receptor (GR), Forkhead box (Fox), MYC
associated factor X (MAX), Insulin Promoter Factor 1 (IPF1), TGFB-Induced Factor Homeobox 1 (TGIF1), hepatic nuclear factor 3 beta (HNF3beta),
Octamer-Binding Protein 1 (Oct1), No data (ND), quiescent, low transcription (Q/L), weak transcription (WT), strong transcription (ST), weak repressed
polycomb (WRPC), active transcription start site (ATSS), ﬂanking active transcription start site (FATSS), ﬂanking bivalent transcription start site (FBTSS),
enhancer (E).
doi:10.1371/journal.pgen.1006104.t002
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future studies. Finally, more recently it was discovered that etv5 co-expressed with tyrosine
hydroxylase in the brain of a cichlid fish, Astatotilapia burtoni, but no functional analysis was
undertaken in this study [49].
Our study indicates that in Drosophila Ets96B is necessary to inhibit dopamine signalling.
In fact, our results indicate that in the fruit fly Ets96B acts to repress the expression of more
Fig 10. Human ERmolecular chaperon SNPs associated with bodymass index and bipolar disorder. (A) Summary figure of SNP
association results from Genome Central [39] for PDIA3, PDIA6 andHYOU1 linkage to body mass index (BMI), Weight-hip ratio and bipolar
disorder. Horizontal axis lists significant SNPs and genes. The red line represents P = 0.05 nominal significance level; above the line
represents significant results. (B) Linkage disequilibrium between SNPs in PDIA6. Boxes = exons, lines between boxes = introns, The LD
between SNPs in the CEU population is expressed as R2 and displayed as a color code below the plot. (C) Linkage disequilibrium between
SNPs in HYOU1. Boxes = exons, lines between boxes = introns, The LD between SNPs in the CEU population is expressed as R2 and
displayed as a colour code below the plot.
doi:10.1371/journal.pgen.1006104.g010
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genes that it activates. Possibly, there are co-factors that interact with Ets96B to govern if it is a
transcriptional repressor or activator. There is evidence for this with other Ets-family members.
For instance, in both mammals and Drosophila, Ets-1 (known as Pointed in Drosophila) can
act as an activator or inhibitor depending on interactions with Runx1 (known as Lozenge in
Drosophila) [53, 54]. Depending on temporal or spatial differences, this interacting protein
may or may not be present, meaning in some tissues or conditions Ets96B would act as a tran-
scriptional activator, while under other conditions it would act as a repressor. Given that our
whole transcriptome sequencing was performed on material collected from well fed, equally
aged, whole male adults, our results cannot determine if this is the case.
The largest group of genes affected by loss of Ets96B throughout development in the Dro-
sophila nervous system is involved in oxidation/reduction, including those regulating mito-
chondrial electron transport (see Table 1). Interestingly, many studies have linked the
mitochondrial electron transport chain to obesity, as well as insulin resistance [55–58]. This
includes COX1 and CYTB, human homologues of two genes (mt:Col andmt:Cyt-b) overex-
pressed when Ets96B is knocked down in the CNS, which are linked to insulin sensitivity [59,
60]. Lower expression levels of these two genes correlates with insulin resistance [60]. Further-
more, an association with obesity was found for a frequent allele of the human ATP6 gene [61,
62]. Similar tomt:Col andmt:Cyt-b, the Drosophila homolog of ATP6,mt:ATPase6, is also
upregulated when Ets96B is knocked down in the CNS.
When Ets96B is knocked down in the nervous system during development a group of con-
served interacting endoplasmic reticulum (ER) proteins are highly upregulated: CaBP1, Crc
and ERp60 (see Fig 3A and 3B). All three proteins localize to the ER, where they are involved in
the regulation of protein folding. Also, human homologues of CaBP1 and ERp60, known as
PDIA6 and PDIA3, are involved in disulfide bridge formation (see Fig 3E). Of note, insulin
contains three important disulphide bonds that are conserved in Drosophila insulin-like pep-
tides, and recently it was demonstrated that Etv5 knockout mice are deficient in insulin secre-
tion [43], though not due to a decrease in insulin production. Disulphide bonds are important
for proper protein folding, secretion and function, and disruption of disulfide bond formation
in insulin proteins could inhibit proper secretion.
Previously, it was demonstrated that Crcmutant flies fail to react when startled [36, 63].
Interestingly, we observed that adult males have a heightened startle-response when Ets96B is
knocked down in the CNS during development, but when Ets96B expression is specifically
knocked down in adults there is no difference in activity compared to control flies. Further-
more, compared to controls, knocking down Ets96B expression throughout development
induces hyperactivity. When Crc was mutated, the mushroom bodies and ellipsoid body were
smaller than normal. Ets96B is also expressed in the mushroom bodies and the ellipsoid body
of the Drosophila CNS [32]. The mushroom bodies are the centre of learning and memory [64]
while the ellipsoid body mediates stress-related locomotion [65, 66], and both regions are
important components of the dopamine and serotonin systems [65, 66]. In Drosophila the
ellipsoid body regulates the startle-response; more specifically, dopaminergic neurons within
the ellipsoid body regulate the arousal-response to being startled [67]. Possibly, through its reg-
ulation of the molecular chaperon complex, Ets96B controls the proper development or signal-
ling of dopaminergic neurons within the mushroom bodies and the ellipsoid body.
Interestingly, when murine dopaminergic neurons are put under stress they upregulate the Crc
homologue Calreticulin (Calr) [20, 21]. Furthermore, rat brains, exposed to neurotoxic
6-hydroxydopamine, induce the expression of not only Calr, but also Pdia3 (Drosophila
ERp60) [68]. Furthermore, in C. elegans, CRT-1 (Calr) was necessary for regenerative neuronal
outgrowth from neuronal injury [69]. This leads to the possibility that lowering Ets96B expres-
sion throughout development is neuroprotective and actually leads to increased dopaminergic
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signalling in adults due to increased dopaminergic neuronal innervations. In regions of the
human brain linked to bipolar disorder, such as the anterior caudate and mid-frontal lobe [70],
the ETV5-linked SNP rs7433760 mapped to an enhancer specific for those regions (see S4 Fig).
Thus, a decrease in ETV5 expression could lead to increased dopaminergic signalling.
When Ets96B is knocked down in the nervous system during development, phenotypes
mimicking obesity (increased lipid storage) and bipolar disorder (startle-response and dis-
rupted sleep) are observed. Of note, we found 12 ETV5 localized SNPs that link to BMI, of
which three also link to BD (see Fig 9, as well as S2 Table and S4 Fig). Intriguingly, HSP90B1
(Drosophila Gp93) and CALR (Drosophila Crc), homologues of molecular chaperones upregu-
lated when Ets96B was knocked down in the nervous system, are not properly induced during
increased endoplasmic reticulum (ER) stress in lymphoblastoid cells recovered from bipolar
disorder patients [18]. Furthermore, we also found multiple SNPs that localize to PDIA3,
PDIA6 andHYOU1 that link to either BMI or bipolar disorder (see Fig 10A).
Another possibility of how disruption of ER localized molecular chaperone expression may
link to obesity and/or BD is increased expression of vesicle monoamine transporter 2
(VMAT2), which concentrates monoamine neurotransmitters into synaptic vesicles. Our
results show that loss of Ets96B in dopaminergic neurons is sufficient to increase tryosine
hydroxylase (ple) Vmat expression and decrease DAT expression, which would lead to
increased dopamine signalling. Mammalian VMAT2 contains a disulphide bridge in its vesicu-
lar luminal loops that contributes to efficient monoamine transport [71]. This could be
enhanced by increased expression of PDIA3, PDIA6 or CALR, whose Drosophila homologues,
CaBP1, ERp60 and Crc, were all upregulated when Ets96B was knocked down in the nervous
system. Increased VMAT2 function would influence monoamine signalling, including dopa-
mine and serotonin. Vmat2 expression levels are reduced in Flinders sensitive line (FSL) rats,
which represent a genetic animal model for clinical depression in humans [72, 73]. This sug-
gests that alterations in VMAT2 may play a role in the aetiology of depression and anxiety.
Interestingly, reduced Vmat2 levels were localized to the ventral tegmental area and the sub-
stantia nigra in FSL rats, regions that express Etv5 in mice [9, 73]. Interestingly, in FSL rats, the
reduced levels of Vmat2 protein were not caused by a reduction in Vmat2mRNA levels. Thus,
the activity of Vmat2 in FSL rat brain is likely not affected at the transcriptional level, but at the
functional level.
In conclusion, here we identify a specific molecular link between obesity and bipolar disor-
der, both conditions with highly complex and overlapping genetics and pathophysiology. We
found that Ets96B regulates the expression of cellular systems with links to obesity and behav-
iour, with phenotypes at the physiological level in the mutant flies supportive of these findings.
In particular, we find that Ets96B inhibits the expression of a conserved ER molecular chaper-
one complex shown to be neuroprotective in dopaminergic neurons. Furthermore, Ets96B is
expressed in a subset of dopaminergic neurons in adult males and loss of Ets96B specifically in
dopaminergic neurons influences the expression of genes involved in dopamine production,
release and reuptake and would increase dopamine signalling. Finally, the new association of
ETV5 to human bipolar disorder emphasizes a functional relationship between obesity and BD
at the molecular, as well as behavioural level.
Methods
Fly stocks and maintenance
w, P{w[+mW.hs]=GawB}elav[C155], w1118;P{y[+t7.7] w[+mC] = GMR36H05-GAL4}attP2 P
{GawB}elavC155 w; P{FRT(whs)}G13 P{tubP-GAL80}LL2, and the w; P{w[+mC] = ple-GAL4.
F}3 driver lines, the w; UAS-GFP line, as well as the Transgenic RNAi Project (TRiP) [25]
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RNAi lines y1,sc,v1;P{TRiP.HMS00092}attP2 (Ets96BRNAi1) and y1, v1; P{TRiP.JF02226}attP2
(Ets96BRNAi2) and the RNAi lines w1118;P{w[+mC] = UAS-GFP.dsRNA}143 (GFPRNAi1) and
w1118;P{w[+mC] = UAS-GFP.dsRNA}142 (GFPRNAi2) [74] were received from the Bloomington
Stock Center (Bloomington, Indiana, USA; http://flystocks.bio.indiana.edu/). All strains were
crossed into the same w1118 genetic background. All flies, unless otherwise stated, were main-
tained on Jazz mix standard fly food (Fisher Scientific, Göteborg, Sweden), supplemented with
5% Brewer’s yeast extract (VWR, Stockholm, Sweden). Flies were maintained at 25°C in an
incubator at 60% humidity on a 12:12 light:dark cycle. Flies crossed to GAL4 drivers (GAL4
drivers crossed to UAS-RNAi lines) and controls (GAL4 drivers or UAS-RNAi crossed to
w1118) were raised at 25oC until the adults emerged (F1 generation); once collected adults were
raised at 29oC for the appropriate times. All assays were performed at 25°C. In all assays, the
GAL4 drivers and UAS transgenic flies were crossed to w1118 flies and their F1 progeny used as
controls.
Multiple sequence alignments and Phylogenetic analysis
The protein sequences used for the sequence alignment and phylogenetics analysis were mined
using Flybase (www.flybase.org), NCBI HomoloGene (www.ncbi.nlm.nih.gov/homologene),
and Hmmer (www.ebi.ac.uk/Tools/hmmer/). Protein sequences were aligned using CLC
sequence Viewer 6 using default parameters. The sequence alignment used for phylogenetic
analysis was exported in clustal format and viewed using MEGA5 [75]. The file was then trans-
formed into a MEGA file for further analysis. Evolutionary history was inferred using the Max-
imum-likelihood method. The optimal tree with the sum of branch length = 3.794 is shown.
The percentage of replicate trees in which the associated taxa clustered together in the boot-
strap test (5000 replicates) is shown next to the branches. The tree is drawn to scale, with
branch lengths in the same units as those of the evolutionary distances used to infer the phylo-
genetic tree. The evolutionary distances were computed using the Dayhoff matrix based
method and are in the units of the number of amino acid substitutions per site. The rate varia-
tion among sites was modelled with a gamma distribution (shape parameter = 5). The analysis
involved 35 amino acid sequences. All positions containing gaps and missing data were elimi-
nated. There were a total of 170 positions in the final dataset. Evolutionary analyses were con-
ducted in MEGA5 [75].
Library preparation and sequencing
Primary processing of SOLiD RNA-Seq reads. RNA-seq reads for whole transcriptome
were obtained using SOLiD 5500xl paired end sequencing from life technologies. This version
produces read length of 75 bp for fragment libraries with the alternative to sequence an addi-
tional 35 bp in the reverse direction (paired-end sequencing). The samples were divided into
six libraries and since the libraries were molecularly bar-coded the separation of libraries for
control and experimental samples was done effortlessly using respective barcodes. The initial
quality analysis was performed using a propriety tool 'XSQ Tools package' provided by the life
technologies. This package also provides tools for converting files from XSQ to csfasta format
and additionally provides qual files containing read quality information. Further analysis was
done using the 'Tuxedo suit' [76] composed mainly of three tools TopHat, Cufflinks and
CummRbund.
Mapping of RNA-Seq reads using TopHat. TopHat (v2.0.6) incorporates an ultra high-
throughput short read aligner Bowtie (version 0.12.7) [77] as alignment engine. Based on pro-
vided quality control information TopHat removes a portion of reads and maps the remaining
reads to reference genome. Reads were then aligned to the D.melanogaster reference genome
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(build dmel_r5.47_FB2012_05) obtained from flybase using TopHat using the prebuilt bowtie
index downloaded from the TopHat homepage (http://TopHat.cbcb.umd.edu/igenomes.
shtml).
Transcript assembly and abundance estimation using Cufflinks. The aligned reads were
then processed by Cufflinks v2.0.2. Cufflinks tool estimates the relative abundances of tran-
scripts based on how many reads support each transcript, taking into account biases in library
preparation protocols and reports it in “fragments per kilobase of transcript per million frag-
ments mapped” or FPKM. Cufflinks constructs a minimum set of transcripts describing the
reads in the dataset rather than using existing gene annotation allowing Cufflinks to identify
alternative transcription and splicing. However it should be noted that Cufflinks (and other
tools too) are dependent on the provided genome annotation and therefore the reported
FPKM values relate only to genes described and genes missing in the annotation description
file (even though reads map to it) will not be reported.
Differential expression testing using Cuffcompare and Cuffdiff. Cuffcompare was used
to produce combined General Transfer Format (GTF) files of the six libraries. The GTF files
were then passed to cuffdiff along with original alignments obtained with TopHat. Cuffdiff re-
estimates the abundance of transcripts listed in.GTF files using alignment files. The differential
expression is checked for genes, transcripts and isotopes. By tracking changes in the relative
abundance of transcripts with a common transcription start site, cuffdiff can identify changes
in splicing. We used cuffdiff to compare expression difference between three stages of controls
and one experimental sample wherein gene ETS96B was down regulated. Cuffdiff learns how
read counts vary for each gene across the replicates and uses these variance estimates to calcu-
late the significance of observed changes in expression. The calculated P value and q value (the
FDR-adjusted P value of the test statistic) from cuffdiff were used to determine significance of
differential expression The significance depends on whether P is greater than the false discov-
ery rate (FDR) after a Benjamini-Hochberg correction [78] for multiple testing
RNA purification
The phenol-chloroform method was used for RNA extraction from tissue samples [79]. Fifty
fly heads were homogenized with 800 μl TRIzol (ThermoFisher Scientific, MA, USA), 200 μl
Chloroform (Sigma-Aldrich, MO, USA) was added and samples were centrifuged at 12000
rpm for 15 minutes at 4°C. The aqueous layer, which contained RNA, was separated and 500 μl
isopropanol (Solvaco AB, Sweden) was added. The RNA was precipitated by storing the sam-
ples at -32°C for 2 hours. Samples were centrifuged at 12000 rpm for 10 minutes at 4°C, to col-
lect the RNA pellets, which were then washed with 75% ethanol (Solvaco AB, Sweden) to
remove the organic impurities. Samples were allowed to air dry to remove any traces of ethanol.
Dried RNA pellets were dissolved in 21.4 μl of RNAse free water (Qiagen GmBH, Germany)
and 2.6 μl of DNAse incubation buffer (Roche GmBH, Germany). The samples were incubated
at 75°C for 15 minutes to ensure complete dissolution of RNA-pellets. 2 μl of DNAse I (10 U/
μl, Roche GmBH, Germany) was added to each sample, and incubated at 37°C for 3 hr to
remove DNA contamination. DNAse was deactivated by incubating the samples at 75°C for 15
minutes. Removal of DNA was confirmed by PCR using Taq polymerase (5U/μl, Biotools B &
M Labs, Spain), followed by agarose gel electrophoresis. The RNA concentration was measured
using a nanodrop ND 1000 spectrophotometer (Saveen Werner).
cDNA synthesis
cDNA was synthesized from RNA template using dNTP 20 mM (ThermoFisher Scientific,
MA, USA), random hexamer primers and M-MLV Reverse Transcriptase (200 U/μl,
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ThermoFisher Scientific, MA, USA) by following manufactures instructions. cDNA synthesis
was confirmed by PCR followed by agarose gel electrophoresis.
qRT-PCR
Relative expression levels of three housekeeping genes (EF-1, Rp49& RpL11) and of the genes of
interest were determined with quantitative RT-PCR (qPCR). Each reaction, with a total volume
of 20 μl, contained 20 mMTris/HCl pH 9.0, 50 mMKCl, 4 mMMgCl2, 0.2 mM dNTP, DMSO
(1:20) and SYBR Green (1:50000). Template concentration was 5 ng/μl and the concentration of
each primer was 2 pmol/μl. Primers were designed with Beacon Designer (Premier Biosoft) using
the SYBR Green settings. All qPCR experiments were performed in duplicates; for each primer
pair a negative control with water and a positive control with 5 ng/μl of genomic DNA were
included on each plate. Amplifications were performed with 0.02 μg/ml Taq DNA polymerase
(Biotools, Sweden) under the following conditions: initial denaturation at 95°C for 3 min, 50
cycles of denaturing at 95°C for 15 sec, annealing at 52.8–60.1°C for 15 sec and extension at 72°C
for 30 sec. Analysis of qPCR data was performed using MyIQ 1.0 software (Bio-Rad, CA, USA)
as previously reported [80]. Primer efficiencies were calculated using LinRegPCR [81] and sam-
ples were corrected for differences in primer efficiencies. The GeNorm protocol described by
Vandesompele et al. [82] was used to calculate normalization factors from the expression levels
of the housekeeping genes. Grubbs' test was performed to remove outliers. Differences in gene
expression between groups were analyzed with ANOVA followed by Fisher's PLSD test where
appropriate. P<0.05 was used as the criterion of statistical significance. The following primers
were used: EF-1 F: 5´-GCGTGGGTTTGTGATCAGTT-3´, R: 5´-GATCTTCTCCTTGCCCA
TCC-3´; Rp49 F: 5´-CACACCAAATCTTACAAAATGTGTGA-3´, R: 5´-AATCCGGCCTTGC
ACATG-3´; RpL11 F: 5´-CCATCGGTATCTATGGTCTGGA-3´, R: 5´-CATCGTATTTCTGCT
GGAACCA-3´, Ets96B F: 5´-CCTCCATAGACTACCATAT-3´, R: 5´-GTAACTCAACCTCAA
TGC-3´; CaBP1 F: 5´-GCAGCGTTAGTGCCTTCTATT-3´, R: 5´-CTTTCAGCACCTCCCGG
TC-3´; ERp60 F: 5´-GACTTTGCCACCACCCTAAAA-3´, R: 5´-TACTCGGGCTTCAATCGC
TTG-3´; Crc F: 5´-GAAAACTGGGAGGATACGTGG-3´, R: 5´-GAGAGGTCTGAATGCCT
TTGTC-3´; ple F: 5´-CGAGGACGAGATTTTGTTGGC-3´, R: 5´-TTGAGGCGGACCACCA
AAG-3´; Vmat F: 5´-CGTGACCTTCGGGACGATAG-3´, R: 5´-ACTAGAGCGGGAAAACC
AGC-3´; DAT F: 5´-GCTTCAAACCATAAGTTCTAA-3´, R: 5´-TCGGACTTGATATTATCT
ACAA-3´
Starvation assay
Starvation resistance assay was performed in a similar fashion as Hergarden et al (2012) [33]
Starvation resistance was measured by placing 30, 5 to 7 days old, male flies in individual tubes
containing 1% agarose in the Drosophila activity monitoring system (DAMS) (Trikinetics,
MA, USA). DAMS was performed at 25°C in an incubator, on a 12h:12h light:dark cycle.
Triacylglycerol determination
Flies (25 males) were homogenized with 100 μl of PBST buffer (1x phosphate buffer with 10%
Tween20), incubated at 70°C for 5 minutes and then centrifuged at maximum speed for 10
minutes. The supernatant was transferred into a new eppendorff and used as samples. A glyc-
erol standard was used to generate a standard curve with concentrations of 1.0, 0.8, 0.6, 0.4,
and 0.2 mg/ml equivalent triolein concentration. 100 μl of free glycerol reagent was added to
10μl of blank (PBST), standards or samples and initial absorbance at 540nm was measured
after incubation at 37°C for 15 minutes. The concentration of free glycerol in the samples was
calculated from the standard curve generated by this initial absorbance value. Then, 20 μl of
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triglyceride reagent was added in each standard and sample and incubated at 37°C for 15 min-
utes. The final absorbance was taken at 540 nm to calculate triglyceride concentration from the
generated standard curve. The protein concentration of each sample was measured by the Bio-
Rad (Hercules, CA, USA) protein assay kit. The concentrations of free glycerides and Triglycer-
ides in samples (mg/mg of protein) were calculated from five replicates.
Startle-response assay
Wemeasured startle behaviour as described previously [50]. In brief, single 5–7 day old males
were placed in a plastic culture vial and subjected to a mechanical disturbance by a gentle, yet
sudden, tap of the vial. The vial was then placed horizontally on a bench top. Startle-induced
locomotion was calculated as the number of seconds each fly was active within the 60 s period
following the startle-induced locomotion. All tests were done at 25°C with 3 hours of lights on.
The sample size for all genotypes was N = 50.
DAMS activity assays
Flies were tested using the Drosophila Activity Monitoring System (DAM2, TriKinetics, www.
trikinetics.com). Flies were placed in 5mm x 65mm glass tubes during the morning, with food
placed at one end of the tube. Flies were continually monitored by the use of a light beam, with
the number of beam breaks continuously recorded over a 48 hour period. A light shock or
sound shock stimulus was given approximately one day after the animals were first placed in
the tubes, at 12 noon. The number of beam breaks during the first four hours the flies were
housed in the tube (when the arena is at its most novel and anxiogenic), the half hour prior to
the light shock or sound shock stimulus and the hour post light shock or sound shock stimulus
were all recorded.
Drug treatment
For the pharmacological manipulations 1% agar with 5% sucrose was used as a vehicle
medium. The tyrosine hydroxylase inhibitor, 3-iodo-L-tyrosine (Sigma-Aldrich, Stockholm,
Sweden) was mixed into the medium to a final concentration of 3 mM. There day old male flies
were transferred and kept on the media for 48 hours.
Drosophila brain immunohistochemistry
Male flies were anesthetized and decapitated, and the proboscis was removed. Heads were
placed into a staining glass bowl containing 4% paraformaldehyde in 0.1 M sodium phosphate
buffer (PBS) and left to fixate in the dark for 2 hr on ice. After fixation, heads were placed in a
petri dish containing 4% agarose, and brains were dissected under a light microscope using
fine forceps. Brains were washed four times for 15 min each with 0.1 M PBS. Tissues were
blocked in 10% normal goat serum (NGS) for 1 hr. The NGS was then discarded, and tissues
were incubated with primary antibodies (Millipore, Darmstadt, Germany, anti-GFP chicken
polyclonal diluted 1:200 and Immunostar, Wisconsin, USA, mouse anti-Tyrosine hydroxylase
1:500), diluted in 0.01 M PBS containing 0.25% Triton X-100 (PBX) for 2 days at 4°C. Bowls
were sealed with parafilm and aluminium foil. Following 48 hr of incubation, brains were
washed four times for 15 min each with 0.01 M PBX and incubated with secondary antibody
(ThermoFisher Scientific, MA, USA, goat anti-chicken Alexa Fluor 488 and goat anti-mouse
Alexa Fluor 594 goat anti-rabbit), diluted 1:1000 in 0.01 M PBX, overnight. Bowls were sealed
with parafilm and aluminum foil. Tissues were washed once with 0.01 M PBX for 15 min and
twice with 0.01 M PBS for 15 min. Samples were mounted in Vectashield (Vector Laboratories,
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Peterborough, UK). Images were captured on a Zeiss LSM 510 confocal microscope and visual-
ized using ImageJ.
In situ hybridization
Design and synthesis of RNA probes. Antisense probes were generated from commercial
mouse cDNA clones (Source BioScience). The clones were sequenced (Eurofins MWGOperon,
Germany) and verified to be correct. Plasmids were linearized with appropriate restriction
enzymes and the probes were synthesized using 1μg vector as template with T7, Sp6 or T3
RNA polymerase in the presence of digoxigenin (DIG)-labeled 11-UTP (Roche Diagnostics,
Switzerland). Probes were controlled and quantified using the Nanodrop ND-1000 Spectro-
photometer (NanoDrop Technologies, Delaware, USA).
In situ hybridization on free floating sections. Free floating sections were washed in PBT
followed by 6% hydrogen peroxide treatment at room temperature. After successive washing in
PBT the sections were treated with 20ug/ml proteinase K (Invitrogen). The sections were post-
fixed in 4% formaldehyde before pre-incubation in hybridization buffer (50% formamide,
5xSCC ph4.5, 1% SDS, 50ug/ml tRNA (Sigma Aldrich, Stockholm, Sweden), 50ug/ml heparin
(Sigma Aldrich, Stockholm Sweden) in PBT). Hybridization of sections in presence of 100ng
probe/ml was performed overnight at 58°C. To remove unbound probe the sections were
washed with buffer 1 (50% formamide, 2xSSC ph4.5 and 0.1% Tween-20 in PBT) followed by
buffer 2 (50% formamide, 0.2XSSC ph 4.5 and 0.1% Tween-20 in PBT). The sections were
incubated in blocking solution (1% blocking reagent (Roche Diagnostics, Sweden, Stockholm)
followed by overnight incubation combined with 1:5000 diluted anti-digoxigenin alkaline
phosphates conjugated antibody (Roche Diagnostics Scandinavia, Stockholm, Sweden).
Unbound antibody were washed away with sequential washes with 0.1% Tween-20 tris-buff-
ered saline (TBST). The sections were then developed with Fast Red (Roche diagnostics, Stock-
holm, Sweden).
Ethical statement
All animal procedures were approved by the local ethical committee in Uppsala (permit C 488/
12) and follows international guidelines.
Pairwise linkage disequilibrium
All SNPs in ETV5 or close to ETV5, and that have been associated with BMI and/or dipolar
disorder in genome-wide association studies (GWAS) were selected: rs1356292, rs1516725,
rs1516726, rs4234589, rs4686728, rs4686730, rs6777779, rs6809651, rs7433760, rs9824882,
rs7647305 and rs9816226. P-values of association with BMI and/or bipolar disorder were
retrieved from GWAS central [39]. Pairwise linkage disequilibrium (LD) between the SNPs
were retrieved from SNAP proxy [83], using “1000 Genome Pilot 1” as the SNP data set,
and CEU as the population panel. Fig 9C was generated using the R package LDheatmap
[84].
Statistical analysis
Mean and standard error from all replicates of each experiment was calculated. All analysis
was performed with GraphPad Prism 4, and used ANOVA with appropriate post hoc analy-
sis for multiple comparisons (See figure legends for which analysis was performed for each
assay).
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Supporting Information
S1 Dataset. Excel file containing information about all differentially expressed genes in
adult males where Ets96B (Ets96BRNAi1) has been specifically knocked down in the nervous
system throughout development.
(XLSX)
S1 Fig. Schematic diagram of Ets96B genetic region. Exons represented by black boxes,
introns represented by a line, the open reading frame (ORF) is represented as a blue box. The
enhancer GMR59D04 used to produce the Ets96B-GAL4 transgenic line by Pfeiffer et al (2008)
31 is indicated by a line.
(TIF)
S2 Fig. A CAFE assay was used to assess the total food intake in 5–7 days old adult males.
(A) Ets96B knocked down throughout development using either the pan-neuronal driver elav-
GAL4 or Ets96B-GAL4. Only Ets96BRNAi1 was used for this assay. (n = 50 males per genotype,
one-way ANOVA with Tukey’s post hoc test for multiple comparisons.) Error bars = SEM. (B)
Ets96B knocked down only in adults using the pan-neuronal driver and temperature sensitive
allele of the GAL4 inhibitor GAL80 elav-GAL4, tub-Gal80ts. Only Ets96BRNAi1 was used for this
assay. (n = 50 males per genotype, one-way ANOVA with Tukey’s post hoc test for multiple
comparisons.) Error bars = SEM
(TIF)
S3 Fig. (A) Relative expression level of GFP in 5–7 day old control males (elav-GAL4;
UAS-GFP) or males where GFP was knocked down in the entire nervous system throughout
development. This assay was repeated at least 7 times. (n = 25 males per treatment;  P<0.005
compared with controls, one-way ANOVA with Tukey’s post hoc test for multiple compari-
sons). Error bars = SEM. (B) Relative expression levels of CaBP1, ERp60 and Crc in 5–7 day old
control males (elav-GAL4;UAS-GFP) or males where GFP was knocked down in the entire ner-
vous system throughout development. This assay was repeated at least 7 times. Error bars indi-
cate SEM. (n = 25 males per treatment, one-way ANOVA with Tukey’s post hoc test for
multiple comparisons). (C) Triglyceride levels were determined in male control and GFP
knockdown flies at 0, 12 and 24 hours of starvation. (n = 30 males per treatment, assay was
repeated at least 10 times for each genotype, one-way ANOVA with Tukey’s post hoc test for
multiple comparisons). (D) The DAMS system was used to monitor locomotion in control and
GFP knockdown males prior to and after light stimulation. (n = 30–60 males per strain; One-
way ANOVA with Tukey’s post hoc test for multiple comparisons) In all graphs error
bars = SEM.
(TIF)
S4 Fig. Genome Browser and Encode Roadmap were used to determine the ETV 5 methyla-
tion state in various brain regions. ETV5 SNPs linked to BMI (red) or BMI and biopolar dis-
order (blue) are shown at the bottom. Brain Anterior Caudate (BAC), Brain Cingulate Gyrus
(BCG), Brain Angular Gyrus (BAG), Brain Hippocampus Middle (BHM), Brain Inferior Tem-
poral Lobe (BITL), Brain Mid Frontal Lobe (BMFL), Brain Substantia Nigra (BSN), Fetal Brain
(FB).
(TIF)
S1 Table. Table of graded levels of Etv5mRNA expression in the mouse brain
(PDF)
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S2 Table. Table containing information about human ETV5 localized SNPs associated with
body mass index (BMI) and/or bipolar disorder.
(DOCX)
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